Amrutanjan Health Care Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Sambhu Sivalenka

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	25.8yrs
CEO sahipliği	13.9%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	3.4yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Sambhu Sivalenka'un ücretlendirmesi Amrutanjan Health Care'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	₹426m
Mar 31 2024	n/a	n/a	₹450m
Dec 31 2023	n/a	n/a	₹440m
Sep 30 2023	n/a	n/a	₹373m
Jun 30 2023	n/a	n/a	₹432m
Mar 31 2023	n/a	n/a	₹398m
Dec 31 2022	n/a	n/a	₹418m
Sep 30 2022	n/a	n/a	₹517m
Jun 30 2022	n/a	n/a	₹588m
Mar 31 2022	n/a	n/a	₹672m
Dec 31 2021	n/a	n/a	₹627m
Sep 30 2021	n/a	n/a	₹631m
Jun 30 2021	n/a	n/a	₹668m
Mar 31 2021	n/a	n/a	₹612m
Dec 31 2020	n/a	n/a	₹589m
Sep 30 2020	n/a	n/a	₹474m
Jun 30 2020	n/a	n/a	₹322m
Mar 31 2020	₹13m	₹11m	₹251m
Dec 31 2019	n/a	n/a	₹314m
Sep 30 2019	n/a	n/a	₹274m
Jun 30 2019	n/a	n/a	₹257m
Mar 31 2019	₹13m	₹11m	₹250m
Dec 31 2018	n/a	n/a	₹158m
Sep 30 2018	n/a	n/a	₹168m
Jun 30 2018	n/a	n/a	₹201m
Mar 31 2018	₹13m	₹11m	₹200m

Tazminat ve Piyasa: Sambhu şirketinin toplam tazminatının Indian pazarındaki benzer büyüklükteki şirketlerle karşılaştırıldığında makul olup olmadığını tespit etmek için yeterli veri yok.

Tazminat ve Kazançlar: Sambhu 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Sambhu Sivalenka (50 yo)

25.8yrs

Görev süresi

₹12,759,000

Tazminat

Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Executive Chairman since February 13, 2012. He has been Director...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sambhu Sivalenka	Executive Chairman & MD	25.8yrs	₹12.76m	13.94% ₹ 3.0b
V. Nagaraj	Non-Executive Independent Director	less than a year	Veri yok	Veri yok
Raja Venkataraman	Independent Non-Executive Director	3.5yrs	₹1.95m	Veri yok
Ramaa Arikirevula	Non-Executive Non Independent Director	1.4yrs	₹1.12m	7.76% ₹ 1.7b
Govindan Raghavan	Non-Executive & Non Independent Director	9.5yrs	₹1.50m	0.12% ₹ 26.5m
Muralidharan Swayambunathan	Non-Executive Independent Director	3.4yrs	₹2.07m	Veri yok
Meenalochani Raghunathan	Additional Non-Executive Independent Director	2.3yrs	₹1.49m	Veri yok

3.4yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 590006 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.4 yıldır).

Amrutanjan Health Care Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Amrutanjan Health Care Limited, Annual General Meeting, Sep 23, 2024

Amrutanjan Health Care Limited, Annual General Meeting, Sep 21, 2023

Amrutanjan Health Care Limited Announces Board Changes

Amrutanjan Health Care Limited Appoints Meenalochani Raghunathan as an Additional Director

Non-Executive Independent Director recently bought ₹1.6m worth of stock

Non-Executive Independent Director recently bought ₹549k worth of stock

Recent updates

Amrutanjan Health Care Limited to Report Q2, 2025 Results on Nov 12, 2024

Amrutanjan Health Care Limited Approves Final Dividend for the Year Ended March 31, 2024

Upcoming dividend of ₹2.60 per share

Dividend of ₹2.60 announced

Amrutanjan Health Care Limited, Annual General Meeting, Sep 23, 2024

First quarter 2025 earnings released: EPS: ₹1.60 (vs ₹2.40 in 1Q 2024)

Amrutanjan Health Care Limited to Report Q1, 2025 Results on Aug 13, 2024

New major risk - Earnings quality

Full year 2024 earnings released: EPS: ₹15.50 (vs ₹13.65 in FY 2023)

Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2023-24

Amrutanjan Health Care Limited to Report Q4, 2024 Results on May 23, 2024

Upcoming dividend of ₹1.00 per share at 0.7% yield

Dividend of ₹1.00 announced

Upcoming dividend of ₹1.00 per share at 0.8% yield

Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2023-2024

Amrutanjan Health Care Limited Declares Final Dividend for the Year Ended March 31, 2023

Upcoming dividend of ₹2.60 per share at 0.7% yield

Amrutanjan Health Care Limited, Annual General Meeting, Sep 21, 2023

First quarter 2024 earnings released: EPS: ₹2.40 (vs ₹1.26 in 1Q 2023)

Amrutanjan Health Care Limited to Report Q1, 2024 Results on Aug 02, 2023

Amrutanjan Health Care Limited (BSE:590006) announces an Equity Buyback for 320,000 shares, representing 1.09% for INR 288 million.

Amrutanjan Health Care Limited Announces Board Changes

Investor sentiment improves as stock rises 17%

Full year 2023 earnings released: EPS: ₹13.65 (vs ₹23.00 in FY 2022)

Amrutanjan Health Care Limited to Report Q4, 2023 Results on May 27, 2023

Upcoming dividend of ₹1.00 per share at 0.7% yield

Amrutanjan Health Care Limited Declares Interim Dividend for the Financial Year 2022-23

Third quarter 2023 earnings released: EPS: ₹3.67 (vs ₹7.05 in 3Q 2022)

Amrutanjan Health Care Limited to Report Q3, 2023 Results on Feb 14, 2023

Amrutanjan Health Care Limited Declares First Interim Dividend for the Financial Year 2022-23

Second quarter 2023 earnings released: EPS: ₹4.37 (vs ₹6.79 in 2Q 2022)

Amrutanjan Health Care Limited Announces the Launch of Comfy Period Pain Roll-On

Amrutanjan Health Care Limited to Report Q2, 2023 Results on Nov 04, 2022

Amrutanjan Health Care Limited Approves Final Dividend for the Year Ended March 31, 2022

Upcoming dividend of ₹2.60 per share

First quarter 2023 earnings released: EPS: ₹1.26 (vs ₹4.12 in 1Q 2022)

Amrutanjan Health Care Limited Appoints Meenalochani Raghunathan as an Additional Director

Full year 2022 earnings released: EPS: ₹23.05 (vs ₹20.94 in FY 2021)

Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2021-22

Non-Executive Independent Director recently bought ₹1.6m worth of stock

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Amrutanjan Health Care Limited Declares Second Interim Dividend for the Financial Year 2021-22

Amrutanjan Health Care Limited to Report Q3, 2022 Results on Feb 11, 2022

Second quarter 2022 earnings released: EPS ₹6.79 (vs ₹8.06 in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₹2.60 per share

First quarter 2022 earnings released: EPS ₹4.12 (vs ₹2.20 in 1Q 2021)

Full year 2021 earnings released: EPS ₹20.94 (vs ₹8.58 in FY 2020)

Amrutanjan Health Care Limited Recommends Final Dividend for the Financial Year 2020-21

Non-Executive Independent Director recently bought ₹549k worth of stock

Non-Executive Independent Director recently bought ₹72k worth of stock

Third quarter 2021 earnings released: EPS ₹7.18 (vs ₹3.25 in 3Q 2020)

New 90-day high: ₹586

Amrutanjan Health Care Limited to Report Q3, 2021 Results on Feb 11, 2021

New 90-day high: ₹564

Amrutanjan Health Care Limited Announces Resignation of V. Swaminathan as Non-Executive Independent Director

New 90-day high: ₹518

Market bids up stock over the past week

New 90-day high: ₹487

Amrutanjan Health Care Limited to Report Q2, 2021 Results on Nov 12, 2020

Amrutanjan Health Care Limited Announces Partnership with Chennai Super Kings as Official Pain Relief Partner-Digital for the 2020 Edition of IPL

Amrutanjan Health Care Limited to Report Q1, 2021 Results on Aug 13, 2020

Earnings released

New 90-day high - ₹451

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat